| ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity S Julien, E Adriaenssens, K Ottenberg, A Furlan, G Courtand, ... Glycobiology 16 (1), 54-64, 2006 | 247 | 2006 |
| Exon 14 deleted MET receptor as a new biomarker and target in cancers AB Cortot, Z Kherrouche, C Descarpentries, M Wislez, S Baldacci, ... Journal of the National Cancer Institute 109 (5), djw262, 2017 | 101 | 2017 |
| Identification of new aminoacid amides containing the imidazo [2, 1-b] benzothiazol-2-ylphenyl moiety as inhibitors of tumorigenesis by oncogenic Met signaling A Furlan, F Colombo, A Kover, N Issaly, C Tintori, L Angeli, V Leroux, ... European journal of medicinal chemistry 47, 239-254, 2012 | 91 | 2012 |
| Thirty years of research on met receptor to move a biomarker from bench to bedside A Furlan, Z Kherrouche, R Montagne, MC Copin, D Tulasne Cancer research 74 (23), 6737-6744, 2014 | 80 | 2014 |
| Abl interconnects oncogenic Met and p53 core pathways in cancer cells A Furlan, V Stagni, A Hussain, S Richelme, F Conti, A Prodosmo, A Destro, ... Cell Death & Differentiation 18 (10), 1608-1616, 2011 | 79 | 2011 |
| Hypoxia in solid tumors: how low oxygenation impacts the “Six Rs” of radiotherapy A Rakotomalala, A Escande, A Furlan, S Meignan, E Lartigau Frontiers in endocrinology 12, 742215, 2021 | 67 | 2021 |
| Caspases shutdown nonsense-mediated mRNA decay during apoptosis J Jia, A Furlan, S Gonzalez-Hilarion, C Leroy, DC Gruenert, D Tulasne, ... Cell Death & Differentiation 22 (11), 1754-1763, 2015 | 50 | 2015 |
| Ets‐1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment A Furlan, C Vercamer, X Desbiens, A Pourtier Journal of cellular physiology 215 (3), 782-793, 2008 | 46 | 2008 |
| Ets-1 drives breast cancer cell angiogenic potential and interactions between breast cancer and endothelial cells A Furlan, C Vercamer, L Heliot, N Wernert, X Desbiens, A Pourtier International Journal of Oncology 54 (1), 29-40, 2019 | 41 | 2019 |
| Ets‐1 controls breast cancer cell balance between invasion and growth A Furlan, C Vercamer, F Bouali, I Damour, A Chotteau‐Lelievre, ... International journal of cancer 135 (10), 2317-2328, 2014 | 41 | 2014 |
| ‘Click’synthesis of a triazole-based inhibitor of Met functions in cancer cells F Colombo, C Tintori, A Furlan, S Borrelli, MS Christodoulou, R Dono, ... Bioorganic & medicinal chemistry letters 22 (14), 4693-4696, 2012 | 37 | 2012 |
| Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver A Furlan, F Lamballe, V Stagni, A Hussain, S Richelme, A Prodosmo, ... Journal of hepatology 57 (6), 1292-1298, 2012 | 21 | 2012 |
| Necrosis-and apoptosis-related Met cleavages have divergent functional consequences R Montagne, M Berbon, L Doublet, N Debreuck, A Baranzelli, H Drobecq, ... Cell Death & Disease 6 (5), e1769-e1769, 2015 | 18 | 2015 |
| Control of cell death/survival balance by the MET dependence receptor L Duplaquet, C Leroy, A Vinchent, S Paget, J Lefebvre, F Vanden Abeele, ... Elife 9, e50041, 2020 | 16 | 2020 |
| Combined Drug Action of 2-Phenylimidazo[2,1-b]Benzothiazole Derivatives on Cancer Cells According to Their Oncogenic Molecular Signatures A Furlan, B Roux, F Lamballe, F Conti, N Issaly, F Daian, JF Guillemot, ... Public Library of Science 7 (10), e46738, 2012 | 15 | 2012 |
| H3. 3K27M mutation controls cell growth and resistance to therapies in pediatric glioma cell lines A Rakotomalala, Q Bailleul, C Savary, M Arcicasa, M Hamadou, ... cancers 13 (21), 5551, 2021 | 11 | 2021 |
| FRET image correlation spectroscopy reveals RNAPII-independent P-TEFb recruitment on chromatin G Bidaux, C Le Nézet, MG Pisfil, M Henry, A Furlan, O Bensaude, ... Biophysical Journal 114 (3), 522-533, 2018 | 9 | 2018 |
| An overview of the circadian clock in the frame of chronotherapy: from bench to bedside A Vandenberghe, M Lefranc, A Furlan Pharmaceutics 14 (7), 1424, 2022 | 8 | 2022 |
| Mathematical models converge on PGC1α as the key metabolic integrator of SIRT1 and AMPK regulation of the circadian clock A Furlan, M Jacquier, A Woller, L Héliot, H Duez, B Staels, M Lefranc Proceedings of the National Academy of Sciences 116 (27), 13171-13172, 2019 | 8 | 2019 |
| Evofosfamide is effective against pediatric aggressive glioma cell lines in hypoxic conditions and potentiates the effect of cytotoxic chemotherapy and ionizing radiations Q Bailleul, P Navarin, M Arcicasa, C Bal-Mahieu, AM Carcaboso, ... Cancers 13 (8), 1804, 2021 | 7 | 2021 |
